Torbjørn Bjerke (Karolinska Development AB (Nasdaq Stockholm: KDEV))

Bjerke, Torbjørn (Karolinska Institutet 201306 CEO of Karolinska Development before Orexo CEO before Biolipox CEO)

	Organisation	Karolinska Development AB (Nasdaq Stockholm: KDEV)
	Former/major organisation	Orexo AB (OMX Nordic List, Mid Cap: ORX)
	Group	Orexo (Group)
	Product	pain drug
	Product 2	IP services

Record changed: 2018-05-30

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for Torbjørn Bjerke

[1] Arctic Fund Manamagent. (5/25/18). "Press Release: Two Years of Medical Innovation – [Two Year Anniversary of Arctic Aurora LifeScience Fund]"....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)